Minimal Residual Disease MRD

August 29, 2025

ctDNA Recurrence Monitoring in Endometrial Cancer

Charles H. Weaver, MD
August 28, 2025

Learn how ctDNA testing can help inform breast cancer management

Charles H. Weaver, MD
August 28, 2025

Personalized ctDNA MRD Testing Improves Outcomes in Muscle-Invasive Bladder Cancer

Charles H. Weaver, MD
August 28, 2025

MRD ctDNA Surveillance for Breast Cancer Recurrence

Charles H. Weaver, MD
June 28, 2025

Liquid Biopsy Detects Cancer Progression Much Earlier Than Imaging

Charles H. Weaver, MD
August 9, 2024

Ask the Experts About Circulating Tumor DNA in the Management of Colorectal Cancer

Charles H. Weaver, MD
March 25, 2024

Understanding Cancer Diagnostic Tests: From Early Detection to Personalized Treatment Planning

Charles H. Weaver, MD
December 29, 2023

ctDNA Residual Disease Assessment in Lymphoma

Charles H. Weaver, MD
November 8, 2023

Learn how ctDNA testing can help inform management of lung cancer

Charles H. Weaver, MD
September 1, 2023

Ask The Experts About ctDNA Surveillance Monitoring-Changing the Management of Melanoma

Charles H. Weaver, MD
January 27, 2023

How Precision Medicine in Oncology Has Dramatically Changed the Way Cancer is Diagnosed and Treated

Charles H. Weaver, MD
December 9, 2020

Liquid Biopsies Improve Treatment of Lung Cancer

Charles H. Weaver, MD